Pilot trial of Radioimmunotherapy with Yttrium 90-Labeled (90Y) Zevalin for Low-Grade Follicular Non-Hodgkin's Lymphoma or MALT of the Orbit/Conjunctiva.
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2015
At a glance
- Drugs Ibritumomab tiuxetan (Primary) ; Rituximab
- Indications Non-Hodgkin's lymphoma; Orbital tumours
- Focus Therapeutic Use
- 03 Jun 2015 Last checked against ClinicalTrials.gov record.
- 31 Jul 2012 Actual end date (1 Jul 2012) added as reported by ClinicalTrials.gov.
- 01 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.